Please enable JavaScript to continue using this application.

Compare $CGEM vs $JBIO | Chartloom

Compare

$CGEM vs $JBIO

Cullinan Therapeutics Inc · Jade Biosciences Inc

CGEM

Cullinan Therapeutics Inc

JBIO

Jade Biosciences Inc

Compare $CGEM vs $JBIO

Comparing Cullinan Therapeutics Inc and Jade Biosciences Inc

CGEMCullinan Therapeutics Inc

JBIOJade Biosciences Inc

CGEMCullinan Therapeutics Inc

Market cap

$954M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

53.5%

52W performance

140.8%

FCF yield

-16.7%

JBIOJade Biosciences Inc

Market cap

$876M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

1.6%

52W performance

58.5%

FCF yield

-14.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CGEM

JBIO

Detailed metrics comparison

CGEM

Cullinan Therapeutics Inc

JBIO

Jade Biosciences Inc

Market Cap

CGEM$954M

JBIO$876M

Enterprise Value

CGEM$876M

JBIO$768M

Price

CGEM$15.53

JBIO$14.39

P/E Ratio

CGEMN/A

JBION/A

P/S Ratio

CGEM0.00x

JBIO0.00x

EV/Sales

CGEM0.00x

JBIO0.00x

EV/EBITDA

CGEM8.02x

JBIO0.00x

P/B Ratio

CGEM3.10x

JBIO2.04x

P/FCF Ratio

CGEMN/A

JBION/A

EV/FCF

CGEM-5.50x

JBIO-6.22x

PEG Ratio

CGEMN/A

JBION/A

Forward P/E (NTM)

CGEMN/A

JBION/A

Forward P/S (NTM)

CGEMN/A

JBION/A

Revenue (TTM)

CGEM$0

JBIO$0

Revenue Growth (YoY)

CGEMN/A

JBION/A

Forward Rev Growth

CGEM244.6%

JBIO342.6%

Gross Margin (TTM)

CGEM0.0%

JBIO0.0%

Operating Margin (TTM)

CGEM0.0%

JBIO0.0%

EBITDA Margin (TTM)

CGEM0.0%

JBIO0.0%

Net Margin (TTM)

CGEM0.0%

JBIO0.0%

FCF Margin (TTM)

CGEMN/A

JBION/A

Net Income (TTM)

CGEM$-205M

JBIO$-125M

FCF (TTM)

CGEM$-159M

JBIO$-124M

EPS (TTM)

CGEM-$3.33

JBIO-$2.05

ROE (TTM)

CGEM-5289.0%

JBIO-4911.0%

ROA (TTM)

CGEM-4818.0%

JBIO-4561.0%

ROIC (TTM)

CGEM-5289.0%

JBIO-4911.0%

Cash

CGEM$79M

JBIO$107M

Debt

CGEM$0

JBIO$0

Net Cash/Debt

CGEM$79M

JBIO$107M

Current Ratio (TTM)

CGEM8.42x

JBIO14.93x

Quick Ratio (TTM)

CGEM8.23x

JBIO14.61x

Debt/Equity (TTM)

CGEM0.00x

JBIO0.00x

Debt/Assets (TTM)

CGEM0.0%

JBIO0.0%

Interest Coverage (TTM)

CGEMN/A

JBION/A

Net Debt/EBITDA (TTM)

CGEM0.00x

JBIO0.00x

Beta

CGEM-0.03

JBIO1.78

52W Performance

CGEM140.8%

JBIO58.5%

YTD Performance

CGEM53.5%

JBIO1.6%

% from 52W High

CGEM-33.0%

JBIO-48.6%

% from 52W Low

CGEM138.9%

JBIO72.1%

Asset Turnover (TTM)

CGEM0.00x

JBIO0.00x

FCF Yield (TTM)

CGEM-16.7%

JBIO-14.1%

Earnings Yield (TTM)

CGEM-21.4%

JBIO-14.3%

Dividend Yield (TTM)

CGEMN/A

JBION/A

Rule of 40

CGEM0.0

JBIO0.0

EV/GP/RG

CGEMN/A

JBION/A

Ticker research

View CGEM research View JBIO research

Metric	CGEM Cullinan Therapeutics Inc	JBIO Jade Biosciences Inc
Market & Valuation
Market Cap	$954M	$876M
Enterprise Value	$876M	$768M
Price	$15.53	$14.39
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	8.02x	0.00x
P/B Ratio	3.10x	2.04x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.50x	-6.22x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	244.6%	342.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-205M	$-125M
FCF (TTM)	$-159M	$-124M
EPS (TTM)	-$3.33	-$2.05
ROE (TTM)	-5289.0%	-4911.0%
ROA (TTM)	-4818.0%	-4561.0%
ROIC (TTM)	-5289.0%	-4911.0%
Financial Health
Cash	$79M	$107M
Debt	$0	$0
Net Cash/Debt	$79M	$107M
Current Ratio (TTM)	8.42x	14.93x
Quick Ratio (TTM)	8.23x	14.61x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.03	1.78
52W Performance	140.8%	58.5%
YTD Performance	53.5%	1.6%
% from 52W High	-33.0%	-48.6%
% from 52W Low	138.9%	72.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-16.7%	-14.1%
Earnings Yield (TTM)	-21.4%	-14.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CGEM research	View JBIO research

Valuation

P/S Ratio

CGEM

0.00x

JBIO

0.00x

EV/FCF

JBIO

-6.22x

CGEM

-5.50x

Growth & revenue

Forward Revenue Growth

JBIO

342.6%

CGEM

244.6%

Profitability & performance

Gross Margin

CGEM

0.0%

JBIO

0.0%

ROE

JBIO

-4911.0%

CGEM

-5289.0%

FCF Yield %

JBIO

-14.1%

CGEM

-16.7%

52-Week Performance

CGEM

140.8%

JBIO

58.5%

Detailed metrics comparison

CGEM

Cullinan Therapeutics Inc

JBIO

Jade Biosciences Inc

Market Cap

CGEM$954M

JBIO$876M

Enterprise Value

CGEM$876M

JBIO$768M

Price

CGEM$15.53

JBIO$14.39

P/E Ratio

CGEMN/A

JBION/A

P/S Ratio

CGEM0.00x

JBIO0.00x

EV/Sales

CGEM0.00x

JBIO0.00x

EV/EBITDA

CGEM8.02x

JBIO0.00x

P/B Ratio

CGEM3.10x

JBIO2.04x

P/FCF Ratio

CGEMN/A

JBION/A

EV/FCF

CGEM-5.50x

JBIO-6.22x

PEG Ratio

CGEMN/A

JBION/A

Forward P/E (NTM)

CGEMN/A

JBION/A

Forward P/S (NTM)

CGEMN/A

JBION/A

Revenue (TTM)

CGEM$0

JBIO$0

Revenue Growth (YoY)

CGEMN/A

JBION/A

Forward Rev Growth

CGEM244.6%

JBIO342.6%

Gross Margin (TTM)

CGEM0.0%

JBIO0.0%

Operating Margin (TTM)

CGEM0.0%

JBIO0.0%

EBITDA Margin (TTM)

CGEM0.0%

JBIO0.0%

Net Margin (TTM)

CGEM0.0%

JBIO0.0%

FCF Margin (TTM)

CGEMN/A

JBION/A

Net Income (TTM)

CGEM$-205M

JBIO$-125M

FCF (TTM)

CGEM$-159M

JBIO$-124M

EPS (TTM)

CGEM-$3.33

JBIO-$2.05

ROE (TTM)

CGEM-5289.0%

JBIO-4911.0%

ROA (TTM)

CGEM-4818.0%

JBIO-4561.0%

ROIC (TTM)

CGEM-5289.0%

JBIO-4911.0%

Cash

CGEM$79M

JBIO$107M

Debt

CGEM$0

JBIO$0

Net Cash/Debt

CGEM$79M

JBIO$107M

Current Ratio (TTM)

CGEM8.42x

JBIO14.93x

Quick Ratio (TTM)

CGEM8.23x

JBIO14.61x

Debt/Equity (TTM)

CGEM0.00x

JBIO0.00x

Debt/Assets (TTM)

CGEM0.0%

JBIO0.0%

Interest Coverage (TTM)

CGEMN/A

JBION/A

Net Debt/EBITDA (TTM)

CGEM0.00x

JBIO0.00x

Beta

CGEM-0.03

JBIO1.78

52W Performance

CGEM140.8%

JBIO58.5%

YTD Performance

CGEM53.5%

JBIO1.6%

% from 52W High

CGEM-33.0%

JBIO-48.6%

% from 52W Low

CGEM138.9%

JBIO72.1%

Asset Turnover (TTM)

CGEM0.00x

JBIO0.00x

FCF Yield (TTM)

CGEM-16.7%

JBIO-14.1%

Earnings Yield (TTM)

CGEM-21.4%

JBIO-14.3%

Dividend Yield (TTM)

CGEMN/A

JBION/A

Rule of 40

CGEM0.0

JBIO0.0

EV/GP/RG

CGEMN/A

JBION/A

Ticker research

View CGEM research View JBIO research

Metric	CGEM Cullinan Therapeutics Inc	JBIO Jade Biosciences Inc
Market & Valuation
Market Cap	$954M	$876M
Enterprise Value	$876M	$768M
Price	$15.53	$14.39
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	8.02x	0.00x
P/B Ratio	3.10x	2.04x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.50x	-6.22x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	244.6%	342.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-205M	$-125M
FCF (TTM)	$-159M	$-124M
EPS (TTM)	-$3.33	-$2.05
ROE (TTM)	-5289.0%	-4911.0%
ROA (TTM)	-4818.0%	-4561.0%
ROIC (TTM)	-5289.0%	-4911.0%
Financial Health
Cash	$79M	$107M
Debt	$0	$0
Net Cash/Debt	$79M	$107M
Current Ratio (TTM)	8.42x	14.93x
Quick Ratio (TTM)	8.23x	14.61x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.03	1.78
52W Performance	140.8%	58.5%
YTD Performance	53.5%	1.6%
% from 52W High	-33.0%	-48.6%
% from 52W Low	138.9%	72.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-16.7%	-14.1%
Earnings Yield (TTM)	-21.4%	-14.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CGEM research	View JBIO research